Dr. Linda Kidder will focus on key life science markets and applications HORIBA Scientific, a global leader in Raman, fluorescence spectroscopy and particle characterization solutions, is pleased announce that Dr. Linda Kidder has joined the company as our new Life Sciences Business Development Manager. Dr. Kidder will focus on developing and expanding our suite of […]

CALGARY  – Nanalysis Scientific Corp. (“Nanalysis” or “the Company”, TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) announces today that Mr. Steve Meszaros has resigned from the company’s board of directors for personal reasons, effective May 13 , 2020. “On behalf of the Board of Directors, I would like to thank Mr. Meszaros for his time and dedication to Nanalysis over the […]

Wesel – Dr. Tammo Boinowitz (53) will become managing director of BYK-Chemie GmbH based in Wesel as of January 1, 2021. After a two-month training and transitional phase, he will also become the President of BYK, the largest division of the specialty chemicals group ALTANA. He succeeds Dr. Christoph Schlünken, who has headed the division on an interim […]

Aldevron Appoints James Brown, Ph.D. President of Research Grade Nucleic Acids Business Unit FARGO, N.D. —  Aldevron, the leading plasmid DNA manufacturing company, has expanded its leadership team by appointing Dr. James Brown President of its Research Grade nucleic acids business unit. Dr. Brown will oversee Aldevron’s strategy to provide plasmids and other nucleic acids […]

Basel — Roche today announced that Michael Varney (1958) Ph.D., and Head of Genentech Research and Early Development (gRED) since 2015, will retire from the company at the end of July.  Aviv Regev (1971), Ph.D., and currently Chair of the Faculty, Core Institute Member, and member of the Executive Leadership Team of the Broad Institute […]

BRANFORD, Conn. — IsoPlexis, the leader in functional cellular proteomics, today announced the appointment of John Strahley as Chief Financial Officer. As CFO, Mr. Strahley will be responsible for the company’s strategic planning, finance, accounting, investor relations, and treasury functions, among other pivotal roles. “We look forward to welcoming John to IsoPlexis’ executive leadership team,” said Sean Mackay, […]

RAINER M. BLAIR TO SUCCEED THOMAS P. JOYCE, JR. AS PRESIDENT AND CEO IN SEPTEMBER 2020 WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher” or “the Company”) today announced that Executive Vice President, Rainer M. Blair, will succeed Thomas P. Joyce Jr. as President and Chief Executive Officer and as a member of the Company’s Board of Directors, upon Mr. […]

London, UK –  The UK genomic tools developer, RevoluGen Ltd., has appointed Sir John Chisholm as non-executive Chairman. Sir John was most recently Executive Chairman of Genomics England in which role he oversaw the world leading 100,000 Genome Project, which led to the UK being the first country to introduce Genomic Medicine into its health system. […]

NEW YORK–Schrödinger (Nasdaq: SDGR), whose physics-based software platform enables discovery of high-quality, novel molecules for therapeutics and materials, today announced the appointments of Jeffrey A. Chodakewitz, M.D., and Gary Ginsberg to its Board of Directors. Dr. Chodakewitz is a veteran in the biopharmaceutical industry who previously held leadership roles at Vertex Pharmaceuticals and Merck & […]